These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 10965936)

  • 1. The effect of the menstrual cycle and of ethinylestradiol on nitric oxide, endothelin-1 and homocysteine plasma levels.
    Merki-Feld GS; Imthurn B; Keller PJ
    Horm Metab Res; 2000 Jul; 32(7):288-93. PubMed ID: 10965936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma endothelin-1, homocysteine and serum nitric oxide values in patients with left-to-right shunt.
    Ozerol IH; Pac FA; Ozerol E; Ege E; Yologlu S; Temel I; Pac M
    Indian Heart J; 2004; 56(6):653-7. PubMed ID: 15751522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytoestrogen alpha-zearalanol antagonizes homocysteine-induced imbalance of nitric oxide/endothelin-1 and apoptosis in human umbilical vein endothelial cells.
    Duan J; Dai S; Fang CX; Sun R; Shavali S; Sharma SK; Ebadi M; Ren J
    Cell Biochem Biophys; 2006; 45(2):137-45. PubMed ID: 16757814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma endothelin level as an endothelial marker of cardiovascular risk in patients with active acromegaly: a comparison with plasma homocysteine.
    Kirilov G; Zacharieva S; Alexandrov AS; Lozanov V; Mitev V
    Methods Find Exp Clin Pharmacol; 2009 Sep; 31(7):457-61. PubMed ID: 19907721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menstrual cyclic variation of endothelium-dependent vasodilation of the brachial artery: possible role of estrogen and nitric oxide.
    Kawano H; Motoyama T; Kugiyama K; Hirashima O; Ohgushi M; Yoshimura M; Ogawa H; Okumura K; Yasue H
    Proc Assoc Am Physicians; 1996 Nov; 108(6):473-80. PubMed ID: 8956371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women].
    Lai A; Zhang J; Ding L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral contraceptives on vascular endothelium in premenopausal women.
    John S; Jacobi J; Schlaich MP; Delles C; Schmieder RE
    Am J Obstet Gynecol; 2000 Jul; 183(1):28-33. PubMed ID: 10920304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis.
    Woolf K; Manore MM
    J Am Diet Assoc; 2008 Mar; 108(3):443-53; discussion 454. PubMed ID: 18313425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in endothelin-1 plasma levels during the menstrual cycle and after ethinylestradiol treatment.
    Merki-Feld GS; Keller PJ
    Ann Intern Med; 1999 Sep; 131(5):394. PubMed ID: 10475898
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse).
    Barbosa IC; Filho CI; Faggion D; Baracat EC
    Contraception; 2006 Jan; 73(1):30-3. PubMed ID: 16371291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.
    Gaspard U; Endrikat J; Desager JP; Buicu C; Gerlinger C; Heithecker R
    Contraception; 2004 Apr; 69(4):271-8. PubMed ID: 15033400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients.
    Cassone Faldetta M; Laurenti O; Desideri G; Bravi MC; De Luca O; Marinucci MC; De Mattia G; Ferri C
    Diabetologia; 2002 Aug; 45(8):1120-7. PubMed ID: 12189442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors.
    Wilcox JG; Hatch IE; Gentzschein E; Stanczyk FZ; Lobo RA
    Fertil Steril; 1997 Feb; 67(2):273-7. PubMed ID: 9022602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers.
    Oelkers W; Helmerhorst FM; Wuttke W; Heithecker R
    Gynecol Endocrinol; 2000 Jun; 14(3):204-13. PubMed ID: 10923282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of endothelin-1 on endothelium-derived vascular responsiveness in man.
    Krum H; Cranswick N; Pellizzer AM
    Clin Sci (Lond); 1998 Aug; 95(2):151-6. PubMed ID: 9680496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen therapy effects on different vasoactive factors in recent postmenopausal healthy women.
    Maffei S; Mercuri A; Zucchelli GC; Vassalle C
    Int J Cardiol; 2006 Feb; 107(2):194-9. PubMed ID: 16412796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen augments the vasodilatory effects of vascular endothelial growth factor in the uterine circulation of the rat.
    Storment JM; Meyer M; Osol G
    Am J Obstet Gynecol; 2000 Aug; 183(2):449-53. PubMed ID: 10942485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.